TITLE

Ambitious plans to roll out ARVs

PUB. DATE
March 2004
SOURCE
HIV Australia;Mar-May2004, Vol. 3 Issue 3, p5
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the plan to launch antiviral treatment programs at several pilot centres for HIV-positive people across Zimbabwe in 2004. Support of the World Health Organization for the program; Cost of a triple generic drug treatment; Reasons for choosing the pilot sites for the program.
ACCESSION #
15003614

 

Related Articles

  • Patient Adherence To HAART Regimens: Challenges For Physician Assistants And Health Care Providers. Day, Marvin // Internet Journal of Academic Physician Assistants;2003, Vol. 3 Issue 1, p42 

    Patients often adhere incompletely and inadequately to highly active antiretroviral therapy (HAART) regimens used in the treatment of HIV infection. This permits the emergence of HIV variants that are resistant to current treatment. The physician assistant often assumes the responsibility for...

  • Antiretroviral access increased but still room for improvement.  // PharmacoEconomics & Outcomes News;4/8/2006, Issue 500, p26 

    According to the latest report issued by the WHO and the Joint United Nations Programme on HIV/AIDS (UNAIDS), the number of patients with HIV infections in low and middle income countries who are receiving antiretroviral (ART) treatments has increased from 400 000 in December 2003 to 1.3 million...

  • Robust treatment programs key to HIV epidemic.  // Nation's Health;Aug2004, Vol. 34 Issue 6, p17 

    This article presents the World Health Report 2004--Changing History which was released by the World Health Organization in May. The World Health Organization, United Nations Joint Program on AIDS and several partners are implementing a comprehensive HIV/AIDS strategy that links prevention,...

  • WHO's use of generic antiretrovirals needs support.  // PharmacoEconomics & Outcomes News;3/12/2005, Issue 473, p2 

    Presents information on a program implemented by the World Health Organization to increase access to antiretrovirals for HIV-infected individuals in developing countries. Efforts to prove the bioequivalence of generic and brand-name antiretrovirals; Criticism of various international agencies...

  • Management of the Adverse Effects of Antiretroviral Therapy and Medication Adherence. Max, Blake; Sherer, Renslow // Clinical Infectious Diseases;6/1/2000 Supplement 2, Vol. 30, pS96 

    Examines the therapeutic agents included in the highly active antiretroviral therapy (HAART) for the treatment of patients with HIV infections. Link between poor adherence and failure of antiretroviral therapy; Threat of short term-adverse effects to successful introduction and maintenance of...

  • Abnormal Cytokine Production by Circulating Monocytes and Dendritic Cells of Myeloid Origin in ART-Treated HIV-1+ Patients Relates to CD4+ T-Cell Recovery and HCV Co-Infection. Almeida, Maria; Cordero, Miguel; Almeida, Julia; Orfao, Alberto // Current HIV Research;Jul2007, Vol. 5 Issue 3, p325 

    HIV-1 infection is associated with dysregulation of cytokine production by peripheral blood (PB) monocytes and dendritic cells (DC), but controversial results have been reported. We aimed to analyze the effect of antiretroviral therapy (ART) on the in vitro production of inflammatory cytokines...

  • Gynaecomastia associated with saquinavir therapy. Donovan, Basil; Bodsworth, Neil J.; Mulhall, Brian P.; Allen, Debbie // International Journal of STD & AIDS;Jan1999, Vol. 10 Issue 1, p49 

    Gynaecomastia has been reported in an HIV-1- infected man treated with a triple antiviral regimen including indinavir1. We describe 4 cases of men with gynaecomastia associated with saquinavir (hard gel capsule) therapy who denied taking any hormonal supplements or opiates.

  • Impact of Indinavir on the Quality of Life in Patients with Advanced HIV Infection Treated with Zidovudine and Lamivudine. Coplan, Paul M.; Cook, John R.; Carides, George W.; Heyse, Joseph F.; Wu, Albert W.; Hammer, Scott M.; Nguyen, Bach-Yen; Meibohm, Anne R.; DiNubile, Mark J. // Clinical Infectious Diseases;8/1/2004, Vol. 39 Issue 3, p426 

    Objective. in AIDS Clinical Trial Group (ACTG) study 320, triple-combination antiretroviral therapy including indinavir significantly slowed progression to acquired immunodeficiency syndrome or death, compared with treatment with dual nucleoside reverse-transcriptase inhibitors (NRTIs) alone, in...

  • Physical Symptoms, Beliefs About Medications, Negative Mood, and Long-Term HIV Medication Adherence. Gonzalez, Jeffrey S.; Penedo, Frank J.; Llabre, Maria M.; Durán, Ron E.; Antoni, Michael H.; Schneiderman, Neil; Horne, Rob // Annals of Behavioral Medicine;2007, Vol. 34 Issue 1, p46 

    Background: Near-perfect levels of HIV medication adherence are necessary for treatment to be successful. However, many patients continue to report nonadherence to HIV treatment. Purpose: This study examines the relationship between symptoms of HIV and medication adherence and evaluates beliefs...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics